We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$20.1B
AUM Growth
+$951M
Cap. Flow
-$224M
Cap. Flow %
-1.12%
Top 10 Hldgs %
32.44%
Holding
721
New
63
Increased
299
Reduced
261
Closed
36

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$55.1M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$46.1M
3
BABA icon
Alibaba
BABA
+$45M
4
NEE icon
NextEra Energy
NEE
+$40.9M
5
AMZN icon
Amazon
AMZN
+$38.3M

Top Sells

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$50.3M
2
META icon
Meta Platforms (Facebook)
META
+$44.2M
3
PG icon
Procter & Gamble
PG
+$34.1M
4
ZTS icon
Zoetis
ZTS
+$33.6M
5
CAH icon
Cardinal Health
CAH
+$32.2M

Sector Composition

Rank Sector Weight
1 Technology 34.01%
2 Healthcare 26.73%
3 Financials 11.13%
4 Consumer Discretionary 7.93%
5 Communication Services 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COF icon
201
Capital One
COF
$130B
$17.9M 0.09%
73,678
+6,444
+10% +$1.43M
SQM icon
202
Sociedad Química y Minera de Chile
SQM
$19.1B
$17.7M 0.09%
256,600
+17,718
+7% +$976K
DGX icon
203
Quest Diagnostics
DGX
$26B
$17.7M 0.09%
101,727
+29,908
+42% +$5.45M
INTU icon
204
Intuit
INTU
$85.6B
$17.4M 0.09%
26,337
+363
+1% +$240K
VNO icon
205
Vornado Realty Trust
VNO
$7.54B
$17.3M 0.09%
521,253
-264,160
-34% -$9.65M
IMVT icon
206
Immunovant
IMVT
$7.99B
$17.3M 0.09%
+680,372
New +$15.2M
OLMA icon
207
Olema Pharmaceuticals
OLMA
$1.01B
$17M 0.08%
679,484
-570,243
-46% -$10.1M
EXAS
208
DELISTED
Exact Sciences
EXAS
$16.9M 0.08%
166,157
-179,242
-52% -$14.4M
VZ icon
209
Verizon
VZ
$201B
$16.6M 0.08%
407,288
-3,706
-0.9% -$150K
BRO icon
210
Brown & Brown
BRO
$25B
$16.5M 0.08%
207,323
-10,215
-5% -$852K
FCX icon
211
Freeport-McMoran
FCX
$88.6B
$16.5M 0.08%
324,642
-161,486
-33% -$7M
TXN icon
212
Texas Instruments
TXN
$253B
$16.4M 0.08%
94,344
+1,668
+2% +$286K
PDD icon
213
Pinduoduo
PDD
$122B
$15.9M 0.08%
139,800
-35,200
-20% -$4.37M
KYMR icon
214
Kymera Therapeutics
KYMR
$8.73B
$15.7M 0.08%
201,672
+10,033
+5% +$678K
ANET icon
215
Arista Networks
ANET
$214B
$15.5M 0.08%
117,935
+4,120
+4% +$567K
ELV icon
216
Elevance Health
ELV
$83.7B
$15.4M 0.08%
43,840
-5,418
-11% -$1.83M
NEM icon
217
Newmont
NEM
$96.4B
$15.3M 0.08%
152,936
-5,870
-4% -$530K
EQIX icon
218
Equinix
EQIX
$102B
$15.2M 0.08%
19,901
-64,227
-76% -$50.3M
GH icon
219
Guardant Health
GH
$19B
$15.2M 0.08%
148,406
-23,347
-14% -$2.09M
MGA icon
220
Magna International
MGA
$18.8B
$14.7M 0.07%
275,637
+29,250
+12% +$1.43M
APGE icon
221
Apogee Therapeutics
APGE
$10.1B
$14.4M 0.07%
191,318
+65,237
+52% +$4.11M
JXN icon
222
Jackson Financial
JXN
$8.57B
$14.4M 0.07%
135,343
-19,060
-12% -$1.9M
STOK icon
223
Stoke Therapeutics
STOK
$1.83B
$14.2M 0.07%
+446,690
New +$13.4M
FERG icon
224
Ferguson
FERG
$45B
$14.1M 0.07%
63,173
+1,291
+2% +$308K
MHK icon
225
Mohawk Industries
MHK
$7.14B
$14M 0.07%
128,400
+104,441
+436% +$12M
7 8
9
10 11

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2025 Portfolio in Review

As of Q4 2025, Candriam SCA held 721 positions worth $20.1B, up 5% from $19.1B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q4 2025 filing shows 63 new, 299 increased, 261 reduced and 36 closed positions. Its largest new stake was Alibaba: 276,080 shares worth $40.5M. The largest sale was Equinix, an estimated $50.3M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q4 2025 buy was Alibaba: 276,080 shares worth $40.5M.
  • Candriam SCA added most to AbbVie in Q4 2025, an estimated $55.1M increase.
  • Candriam SCA's biggest Q4 2025 reduction was Equinix, cutting an estimated $50.3M.
  • Candriam SCA fully exited Universal Display in Q4 2025, selling an estimated $27.1M.
  • Candriam SCA's ten largest holdings make up 32% of its $20.1B portfolio in Q4 2025.
  • Candriam SCA opened 63 new positions and closed 36 in Q4 2025.
  • Candriam SCA's portfolio value rose 5% quarter-over-quarter to $20.1B.

Based on Candriam SCA's 13F filing for Q4 2025, filed 13 Feb 2026.